Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7850962 Human monoclonal antibodies against CD20

Patent 7850962 was granted and assigned to Genmab A/S on December, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
‌
Genmab A/S
Date Filed
April 20, 2005
Date of Patent
December 14, 2010
Patent Application Number
11578818
Patent Citations Received
‌
US Patent 12129309 Heterodimeric antibodies that bind CD3 and CD38
0
‌
US Patent 11673972 Heterodimeric antibodies that bind CD3 and tumor antigens
0
‌
US Patent 11859012 Heterodimeric antibodies that bind CD3 and GPC3
0
‌
US Patent 11919956 Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3
0
‌
US Patent 11945880 Heterodimeric antibodies that bind CD3 and tumor antigens
0
Patent Inventor Names
Jessica Teeling
0
Martin Glennie
0
Paul Parren
0
Sigrid Ruuls
0
Yvo Graus
0
Arnout F. Gerritsen
0
Jan van de Winkel
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7850962
Patent Primary Examiner
‌
Anne M. Gussow

Find more entities like US Patent 7850962 Human monoclonal antibodies against CD20

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo